The US Food and Drug Administration has implemented a full complement of coronavirus containment measures, including travel and meeting restrictions, that might endanger user fee goals and by extension product approvals.
Not only has all non-essential travel been cancelled for the next several weeks, including non-mission-critical inspections, but all Center for...








